Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · IEX Real-Time Price · USD
0.0237
-0.0009 (-3.66%)
At close: Apr 12, 2024, 3:59 PM
0.0221
-0.0016 (-6.75%)
After-hours: Apr 12, 2024, 7:59 PM EDT

Company Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States.

It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone.

The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Sintx Technologies, Inc.
Sintx Technologies logo
Country United States
Founded 1996
IPO Date Feb 13, 2014
Industry Medical Devices
Sector Healthcare
Employees 41
CEO Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D.

Contact Details

Address:
1885 West 2100 Street
Salt Lake City, Utah 84119
United States
Phone 801-839-3516
Website sintx.com

Stock Details

Ticker Symbol SINT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001269026
CUSIP Number 829392307
ISIN Number US8293926049
SIC Code 3841

Key Executives

Name Position
Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. Chief Executive Officer, President, Principal Financial Officer and Chairman
David Francis O'Brien Executive Vice President and Chief Operating Officer
Michael Marcroft Vice President of Sales and Marketing
Gina Moss Director of Operations

Latest SEC Filings

Date Type Title
Apr 12, 2024 8-K Current Report
Apr 5, 2024 PRE 14A Other preliminary proxy statements
Apr 4, 2024 8-K Current Report
Apr 4, 2024 424B5 Filing
Apr 1, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Mar 29, 2024 424B5 Filing
Mar 27, 2024 10-K Annual Report
Mar 26, 2024 8-K Current Report
Mar 26, 2024 424B5 Filing
Mar 22, 2024 424B5 Filing